Open access · OA
via Europe PMC
SIRT1 in Atherosclerosis: Integrative Control of Vascular Metabolism, Inflammation and Aging.
International journal of molecular sciences · 2026
Deregulated nutrient-sensing
Mitochondrial dysfunction
Cellular senescence
Altered intercellular communication
Chronic inflammation
Human
Preclinical / animal
Review
Abstract
Atherosclerosis is a chronic inflammatory and metabolic disease driven by endothelial dysfunction, immune activation, vascular smooth muscle cell remodeling and aging-associated mitochondrial decline. Although lipid lowering remains the cornerstone of therapy, substantial residual inflammatory risk persists, highlighting the need for integrative regulatory targets. Sirtuin 1 (SIRT1), a NAD<sup>+</sup>-dependent deacetylase, has emerged as a central metabolic sensor linking energy availability to transcriptional control of inflammation, oxidative stress, mitochondrial biogenesis and cellular senescence(definition). Experimental studies across endothelial cells, macrophages and vascular smooth muscle cells consistently demonstrate that SIRT1 activation preserves nitric oxide bioavailability, suppresses ROS-dependent inflammasome signaling, modulates macrophage polarization, inhibits ferroptosis and maintains mitochondrial integrity. These cell-type-specific effects converge to reduce plaque progression and enhance fibrous cap stability in preclinical models. However, SIRT1 activity is hierarchically regulated by AMPK signaling and NAD<sup>+</sup> availability and is influenced by aging, metabolic dysfunction and environmental stressors, underscoring its context-dependent function. Despite promising mechanistic data, clinical translation remains limited, suggesting that precision modulation strategies may be required. This review synthesizes current evidence and proposes that SIRT1 functions as a metabolic-inflammatory integrator within the atherosclerotic arterial wall, representing a potential but context-sensitive target for future cardiovascular therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/ijms27073031
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Y, C., L, L., & H., Y. (2026). SIRT1 in Atherosclerosis: Integrative Control of Vascular Metabolism, Inflammation and Aging. <em>International journal of molecular sciences</em>. https://doi.org/10.3390/ijms27073031
Vancouver
Y C, L L, H. Y. SIRT1 in Atherosclerosis: Integrative Control of Vascular Metabolism, Inflammation and Aging. International journal of molecular sciences. 2026. doi:10.3390/ijms27073031.
BibTeX
@article{chang2026SIRTin,
title = {SIRT1 in Atherosclerosis: Integrative Control of Vascular Metabolism, Inflammation and Aging.},
author = {Chang Y and Li L and Yue H.},
journal = {International journal of molecular sciences},
year = {2026},
doi = {10.3390/ijms27073031},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Antioxidants (Basel, Switzerland) 2026
Open access · OA
Sirtuin-1 in Hypertension: Linking Oxidative Stress and Mitochondrial Dysfunction to Vascular Aging and Therapeutic Potential.
Frontiers in pharmacology 2026
Open access · OA
Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways.
European Journal of Pharmacology 2026
Open access · CC-BY
Natural senotherapeutics in respiratory health: Addressing cellular senescence, inflammaging, and immunosenescence in the aging lung
Aging and Cancer 2026
Open access · CC-BY
Natural Products as Geroprotective Modulators in Diabetic Nephropathy: A Mechanistic Framework Integrating Aging Hallmarks and the AMPK–SIRT1–Nrf2 Axis
Physiological genomics 2026
Citation only
Integrated Multi-Omics Network by Physical Exercise Across Aging: Molecular Adaptation Beyond Single Signaling Pathways.
Frontiers in Immunology 2026
Open access · CC-BY